These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
73 related items for PubMed ID: 1782204
1. Analysis of effector cell-derived lyso platelet activating factor by electron capture negative ion mass spectrometry. Christman BW, Gay JC, Christman JW, Prakash C, Blair IA. Biol Mass Spectrom; 1991 Sep; 20(9):545-52. PubMed ID: 1782204 [Abstract] [Full Text] [Related]
2. Analysis of platelet activating factor in human saliva by gas chromatography/mass spectrometry. Christman BW, Blair IA. Biomed Environ Mass Spectrom; 1989 Apr; 18(4):258-64. PubMed ID: 2706378 [Abstract] [Full Text] [Related]
3. Molecular species of platelet-activating factor generated by human neutrophils challenged with ionophore A23187. Oda M, Satouchi K, Yasunaga K, Saito K. J Immunol; 1985 Feb; 134(2):1090-3. PubMed ID: 3917470 [Abstract] [Full Text] [Related]
4. Species-specific variations in the molecular heterogeneity of the platelet-activating factor. Ramesha CS, Pickett WC. J Immunol; 1987 Mar 01; 138(5):1559-63. PubMed ID: 3100641 [Abstract] [Full Text] [Related]
5. Quantitative analysis of platelet activating factor using fast atom bombardment/tandem mass spectrometry. Haroldsen PE, Gaskell SJ. Biomed Environ Mass Spectrom; 1989 Jun 01; 18(6):439-44. PubMed ID: 2504312 [Abstract] [Full Text] [Related]
6. Quantitative analysis of platelet activating factor treated with pentafluorobenzoyl chloride using gas chromatography/negative ion chemical ionization mass spectrometry. Shindo K, Hashimoto Y. Drugs Exp Clin Res; 1991 Jun 01; 17(7):343-9. PubMed ID: 1794300 [Abstract] [Full Text] [Related]
7. Platelet-activating factor in human normal tears. Okumura N, Kojima K, Hashida M, Koura Y, Fukushima A, Ueno H. Curr Eye Res; 2005 Oct 01; 30(10):891-6. PubMed ID: 16251126 [Abstract] [Full Text] [Related]
8. Quantitation of lyso-platelet activating factor molecular species from human neutrophils by mass spectrometry. Haroldsen PE, Clay KL, Murphy RC. J Lipid Res; 1987 Jan 01; 28(1):42-9. PubMed ID: 3104521 [Abstract] [Full Text] [Related]
9. Analysis of phospholipid molecular species in rat lung as dinitrobenzoate diglycerides by electron capture negative chemical ionization mass spectrometry. Haroldsen PE, Murphy RC. Biomed Environ Mass Spectrom; 1987 Oct 01; 14(10):573-8. PubMed ID: 2962658 [Abstract] [Full Text] [Related]
10. Differential electron capture mass spectral response of pentafluorobenzoyl derivatives of platelet activating factor alkyl chain homologs. Weintraub ST, Lear C, Pinckard RN. Biol Mass Spectrom; 1993 Oct 01; 22(10):559-64. PubMed ID: 8218422 [Abstract] [Full Text] [Related]
11. Phorbol diester enhances calcium ionophore A23187-induced [3H]acetate incorporation into platelet-activating factor in murine macrophages: predominant incorporation into 1-O-acyl-2-acetyl-sn-glycero-3-phosphocholine. Wey HE. J Cell Biochem; 1989 Mar 01; 39(3):305-13. PubMed ID: 2496135 [Abstract] [Full Text] [Related]
12. Release of platelet-activating factor and the metabolism of leukotriene B4 by the human neutrophil when studied in a cell superfusion model. Cluzel M, Undem BJ, Chilton FH. J Immunol; 1989 Dec 01; 143(11):3659-65. PubMed ID: 2555414 [Abstract] [Full Text] [Related]
13. Movement of monoglyceride derived from hydrolysis of fluorescence-labeled lyso platelet-activating factor by lysophospholipase C through plasma membranes of porcine kidney epithelial cell line LLC-PK1. Tsutsumi T, Morishige J, Fukuzawa K, Tokumura A. Prostaglandins Other Lipid Mediat; 2007 Feb 01; 83(1-2):33-41. PubMed ID: 17259070 [Abstract] [Full Text] [Related]
14. Characterization of lipoxins by combined gas chromatography and electron-capture negative ion chemical ionization mass spectrometry: formation of lipoxin A4 by stimulated human whole blood. Brezinski DA, Serhan CN. Biol Mass Spectrom; 1991 Feb 01; 20(2):45-52. PubMed ID: 1883860 [Abstract] [Full Text] [Related]
15. Evidence that increasing the cellular content of eicosapentaenoic acid does not reduce the biosynthesis of platelet-activating factor. Triggiani M, Connell TR, Chilton FH. J Immunol; 1990 Oct 01; 145(7):2241-8. PubMed ID: 2118931 [Abstract] [Full Text] [Related]
16. Negative ion electrospray and tandem mass spectrometric analysis of platelet activating factor (PAF) (1-hexadecyl-2-acetyl-glycerophosphocholine). Harrison KA, Clay KL, Murphy RC. J Mass Spectrom; 1999 Apr 01; 34(4):330-5. PubMed ID: 10226361 [Abstract] [Full Text] [Related]
17. Characterization and quantification of PAF-acether (platelet-activating factor) as a heptafluorobutyrate derivative of 1-O-alkyl-2-acetyl-sn-glycerol by capillary column gas chromatography with electron-capture detection. Bossant MJ, Farinotti R, Mencia-Huerta JM, Benveniste J, Mahuzier G. J Chromatogr; 1987 Dec 25; 423():23-31. PubMed ID: 3443654 [Abstract] [Full Text] [Related]
18. Determination of platelet-activating factor and alkyl-ether phospholipids by gas chromatography-mass spectrometry via direct derivatization. Balazy M, Braquet P, Bazan NG. Anal Biochem; 1991 Jul 25; 196(1):1-10. PubMed ID: 1888023 [Abstract] [Full Text] [Related]
19. Quantification of plasma phenylethylamine by combined gas chromatography/electron capture negative ion mass spectrometry of the N-acetyl-N-pentafluorobenzoyl derivative. Durden DA, Davis BA, Boulton AA. Biol Mass Spectrom; 1991 Jun 25; 20(6):375-81. PubMed ID: 1888782 [Abstract] [Full Text] [Related]
20. Opposing effects of platelet-activating factor and lyso-platelet-activating factor on neutrophil and platelet activation. Welch EJ, Naikawadi RP, Li Z, Lin P, Ishii S, Shimizu T, Tiruppathi C, Du X, Subbaiah PV, Ye RD. Mol Pharmacol; 2009 Jan 25; 75(1):227-34. PubMed ID: 18931035 [Abstract] [Full Text] [Related] Page: [Next] [New Search]